ACTRT1
geneOn this page
Also known as AIP1KIAA0705ARIP1Arp-T1
Summary
ACTRT1 (actin related protein T1, HGNC:24027) is a protein-coding gene on chromosome Xq25, encoding Actin-related protein T1 (Q8TDG2). Negatively regulates the Hedgehog (SHH) signaling.
This gene encodes a protein related to the cytoskeletal protein beta-actin. This protein is a major component of the calyx in the perinuclear theca of mammalian sperm heads, and it therefore likely functions in spermatid formation. This gene is intronless and is similar to a related gene located on chromosome 1. A related pseudogene has also been identified approximately 75 kb downstream of this gene on chromosome X.
Source: NCBI Gene 139741 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 87 total — 11 pathogenic
- MANE Select transcript:
NM_138289
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24027 |
| Approved symbol | ACTRT1 |
| Name | actin related protein T1 |
| Location | Xq25 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | AIP1, KIAA0705, ARIP1, Arp-T1 |
| Ensembl gene | ENSG00000123165 |
| Ensembl biotype | protein_coding |
| OMIM | 300487 |
| Entrez | 139741 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000371124
RefSeq mRNA: 1 — MANE Select: NM_138289
NM_138289
CCDS: CCDS14611
Canonical transcript exons
ENST00000371124 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001454396 | 128050962 | 128052403 |
Expression profiles
Bgee: expression breadth tissue_specific, 5 present calls, max score 91.30.
Top tissues by expression
128 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.30 | gold quality |
| right testis | UBERON:0004534 | 61.80 | gold quality |
| testis | UBERON:0000473 | 61.57 | gold quality |
| left testis | UBERON:0004533 | 61.32 | gold quality |
| granulocyte | CL:0000094 | 38.78 | gold quality |
| bone marrow cell | CL:0002092 | 38.12 | gold quality |
| sural nerve | UBERON:0015488 | 37.54 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| bone marrow | UBERON:0002371 | 32.74 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| primary visual cortex | UBERON:0002436 | 30.55 | gold quality |
| prefrontal cortex | UBERON:0000451 | 30.26 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| liver | UBERON:0002107 | 29.59 | gold quality |
| gall bladder | UBERON:0002110 | 28.68 | gold quality |
| tonsil | UBERON:0002372 | 28.64 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| leukocyte | CL:0000738 | 28.00 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| monocyte | CL:0000576 | 27.35 | gold quality |
| islet of Langerhans | UBERON:0000006 | 27.29 | gold quality |
| frontal cortex | UBERON:0001870 | 27.27 | gold quality |
| urinary bladder | UBERON:0001255 | 26.79 | gold quality |
| blood | UBERON:0000178 | 26.46 | gold quality |
| fundus of stomach | UBERON:0001160 | 26.44 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.32 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
1 targets.
| Target | Regulation |
|---|---|
| GLI1 | Repression |
miRNA regulators (miRDB)
3 targeting ACTRT1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5197-5P | 99.64 | 69.08 | 1494 |
| HSA-MIR-532-3P | 99.34 | 65.76 | 1195 |
| HSA-MIR-6730-3P | 97.03 | 67.54 | 889 |
Literature-anchored findings (GeneRIF, showing 4)
- Describes the discovery of two actin-related proteins as major components in a cytoskeletal, nonmotile structure of bull spermatozoa, suggesting that certain members of this family of proteins may serve functions other than nucleation of actin filaments. (PMID:12243744)
- Study identified mutations in the ACTRT1 gene, which encodes actin-related protein T1 (ARP-T1), in two of the six families with Bazex-Dupre-Christol syndrome (BDCS) that were examined in this study. ARP-T1 was found to directly bind to the GLI1 promoter, thus inhibiting GLI1 expression, and loss of ARP-T1 led to activation of the Hedgehog pathway in individuals with BDCS. (PMID:28869610)
- ARP-T1-associated Bazex-Dupre-Christol syndrome is an inherited basal cell cancer with ciliary defects characteristic of ciliopathies. (PMID:33972689)
- Deletion of ACTRT1 is associated with male infertility as sperm acrosomal ultrastructural defects and fertilization failure in human. (PMID:38414365)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Actrt1 | ENSMUSG00000046615 |
| rattus_norvegicus | Actrt1 | ENSRNOG00000003456 |
Paralogs (26): ACTR6 (ENSG00000075089), ACTB (ENSG00000075624), ACTL6B (ENSG00000077080), ACTR5 (ENSG00000101442), ACTR3C (ENSG00000106526), ACTA2 (ENSG00000107796), ACTR8 (ENSG00000113812), ACTR1B (ENSG00000115073), ACTR3 (ENSG00000115091), ACTL8 (ENSG00000117148), ACTR10 (ENSG00000131966), ACTR3B (ENSG00000133627), ACTL6A (ENSG00000136518), ACTR2 (ENSG00000138071), ACTR1A (ENSG00000138107), ACTA1 (ENSG00000143632), ACTL7B (ENSG00000148156), ACTC1 (ENSG00000159251), ACTG2 (ENSG00000163017), ACTBL2 (ENSG00000169067), ACTRT2 (ENSG00000169717), ACTL9 (ENSG00000181786), ACTG1 (ENSG00000184009), ACTRT3 (ENSG00000184378), ACTL7A (ENSG00000187003), ACTL10 (ENSG00000288649)
Protein
Protein identifiers
Actin-related protein T1 — Q8TDG2 (reviewed: Q8TDG2)
All UniProt accessions (1): Q8TDG2
UniProt curated annotations — full annotation on UniProt →
Function. Negatively regulates the Hedgehog (SHH) signaling. Binds to the promoter of the SHH signaling mediator, GLI1, and inhibits its expression.
Subcellular location. Cytoplasm. Cytoskeleton. Nucleus. Cytoplasmic vesicle. Secretory vesicle. Acrosome.
Tissue specificity. In skin, expressed in the basal, spinous and granular layers of the epidermis. Also expressed in hair follicles, sebaceaous glands, eccrine sweat glands and semen.
Disease relevance. Mutations and insertions in the coding sequence or in regulatory non-coding elements of this gene may be associated with Bazex syndrome; a cancer-prone genodermatosis with an X-linked dominant inheritance pattern.
Similarity. Belongs to the actin family.
RefSeq proteins (1): NP_612146* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004000 | Actin | Family |
| IPR043129 | ATPase_NBD | Homologous_superfamily |
Pfam: PF00022
UniProt features (6 total): sequence conflict 3, sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TDG2-F1 | 92.94 | 0.82 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 42 (showing top):
GNF2_RTN1, GCM_MAP4K4, GCM_PTPRD, GOCC_SECRETORY_GRANULE, GOBP_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY, GOBP_SMOOTHENED_SIGNALING_PATHWAY, RFX1_02, GCM_CALM1, GCM_MAPK10, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN, GCM_PTK2, GOMF_CHROMATIN_BINDING, GOCC_SECRETORY_VESICLE, GOCC_ACROSOMAL_VESICLE, GOMF_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON
GO Biological Process (3): regulation of DNA-templated transcription (GO:0006355), regulation of smoothened signaling pathway (GO:0008589), negative regulation of DNA-templated transcription (GO:0045892)
GO Molecular Function (1): chromatin binding (GO:0003682)
GO Cellular Component (6): acrosomal vesicle (GO:0001669), nucleus (GO:0005634), cytoplasm (GO:0005737), actin cytoskeleton (GO:0015629), cytoskeleton (GO:0005856), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 2 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| smoothened signaling pathway | 1 |
| regulation of signal transduction | 1 |
| regulation of DNA-templated transcription | 1 |
| negative regulation of RNA biosynthetic process | 1 |
| binding | 1 |
| secretory granule | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| cytoskeleton | 1 |
| intracellular membraneless organelle | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
1919 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ACTRT1 | TCP11X2 | Q5H9J9 | 620 |
| ACTRT1 | PRR32 | B1ATL7 | 523 |
| ACTRT1 | CTTN | Q14247 | 488 |
| ACTRT1 | HCLS1 | P14317 | 485 |
| ACTRT1 | CCIN | Q13939 | 482 |
| ACTRT1 | ACTRT2 | Q8TDY3 | 449 |
| ACTRT1 | SPATA46 | Q5T0L3 | 432 |
| ACTRT1 | SPANXN4 | Q5MJ08 | 397 |
| ACTRT1 | H2AB3 | P0C5Z0 | 355 |
| ACTRT1 | GMCL2 | Q8NEA9 | 353 |
| ACTRT1 | HUS1B | Q8NHY5 | 353 |
| ACTRT1 | PDCL2 | Q8N4E4 | 343 |
| ACTRT1 | DCAF12L1 | Q5VU92 | 324 |
| ACTRT1 | SPACA5B | Q96QH8 | 320 |
| ACTRT1 | ASB17 | Q8WXJ9 | 315 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| Calml3 | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| PDLIM7 | TPM1 | psi-mi:“MI:0914”(association) | 0.350 |
| PPP1CB | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| MYH9 | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| GAK | PARP10 | psi-mi:“MI:0914”(association) | 0.350 |
| ATG16L1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| ACTRT1 | CCT6A | psi-mi:“MI:0914”(association) | 0.350 |
| ACTRT1 | TCP1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (17): ACTRT1 (Affinity Capture-MS), ACTRT1 (Affinity Capture-MS), ACTRT1 (Affinity Capture-MS), ACTRT1 (Affinity Capture-MS), ACTRT1 (Affinity Capture-MS), PDCL3 (Affinity Capture-MS), USP8 (Affinity Capture-MS), CCT6B (Affinity Capture-MS), CCT2 (Affinity Capture-MS), CCT3 (Affinity Capture-MS), SERPINB9 (Affinity Capture-MS), CCT4 (Affinity Capture-MS), CCT7 (Affinity Capture-MS), CCT6A (Affinity Capture-MS), TCP1 (Affinity Capture-MS)
ESM2 similar proteins: A0JNU3, A2AKE7, A6H603, A6QQ74, D3ZBP4, F1MH07, O43542, Q149M9, Q2T9W4, Q2TA43, Q2V057, Q32KZ2, Q32L91, Q3ZBE0, Q49HH9, Q49KI5, Q4QR76, Q4R317, Q4R6Q3, Q4R821, Q5JWF8, Q5REQ1, Q5XIK1, Q641W9, Q643R3, Q68FW7, Q6AY16, Q6NVG1, Q76HM9, Q86U10, Q8CG27, Q8K4F6, Q8TC94, Q8TDG2, Q8TDY3, Q8TDZ2, Q8VCZ9, Q8VDP3, Q8VEI3, Q95JK8
Diamond homologs: A2WKK5, A2XLF2, A2XNS1, A2ZP58, A3C6D7, D0LWX4, O16808, O18499, O65314, O65315, O65316, O81221, P02576, P04751, P07828, P07830, P07836, P07837, P08023, P0C539, P0C540, P0C542, P0CJ46, P0CJ47, P10981, P12716, P12717, P17126, P17304, P18601, P23343, P24902, P30162, P30164, P30165, P30167, P30168, P30169, P30171, P30172
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
87 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 11 |
| Likely pathogenic | 0 |
| Uncertain significance | 63 |
| Likely benign | 9 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (11)
| Variant ID | HGVS | Classification |
|---|---|---|
| 145170 | GRCh38/hg38 Xq25(chrX:123859097-128717147)x3 | Pathogenic |
| 149087 | GRCh38/hg38 Xq23-27.1(chrX:117260292-140201321)x3 | Pathogenic |
| 149544 | GRCh38/hg38 Xq22.3-28(chrX:106465610-156003242)x1 | Pathogenic |
| 1526848 | GRCh37/hg19 Xq25-26.2(chrX:126307810-131646710) | Pathogenic |
| 208017 | NC_000023.11:g.(?126549383)(129592556_?)del | Pathogenic |
| 4076045 | GRCh37/hg19 Xq24-26.2(chrX:118228490-133002510)x3 | Pathogenic |
| 564888 | GRCh37/hg19 Xq24-27.1(chrX:117998704-140159954)x3 | Pathogenic |
| 564891 | GRCh37/hg19 Xq24-27.1(chrX:120777368-139345946)x1 | Pathogenic |
| 564898 | GRCh37/hg19 Xq25-26.3(chrX:126759247-135790885)x1 | Pathogenic |
| 816382 | GRCh37/hg19 Xq24-26.1(chrX:117119895-129850963)x2 | Pathogenic |
| 980319 | GRCh37/hg19 Xq24-26.1(chrX:117120780-129850994)x3 | Pathogenic |
SpliceAI
83 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:128052156:ACC:A | acceptor_gain | 0.5700 |
| X:128052158:CAT:C | acceptor_gain | 0.5500 |
| X:128052157:C:A | acceptor_gain | 0.5100 |
| X:128052153:T:TA | acceptor_gain | 0.4300 |
| X:128051590:A:AC | acceptor_gain | 0.4200 |
| X:128052154:G:GT | acceptor_gain | 0.4200 |
| X:128052236:C:CT | acceptor_gain | 0.4200 |
| X:128052155:A:AA | acceptor_gain | 0.4000 |
| X:128052237:A:T | acceptor_gain | 0.3700 |
| X:128051228:GAGTA:G | donor_loss | 0.3600 |
| X:128051229:AGTAC:A | donor_loss | 0.3600 |
| X:128051230:GTA:G | donor_loss | 0.3600 |
| X:128051231:TA:T | donor_loss | 0.3600 |
| X:128051232:A:AT | donor_loss | 0.3600 |
| X:128051233:C:CT | donor_loss | 0.3600 |
| X:128051405:G:C | donor_gain | 0.3600 |
| X:128051581:T:C | acceptor_gain | 0.3600 |
| X:128051234:C:G | donor_loss | 0.3500 |
| X:128051580:CT:C | acceptor_gain | 0.3500 |
| X:128051581:TT:T | acceptor_gain | 0.3500 |
| X:128052175:G:GT | acceptor_gain | 0.3500 |
| X:128052257:CGTCA:C | donor_gain | 0.3500 |
| X:128051186:A:C | acceptor_gain | 0.3400 |
| X:128051257:T:TA | donor_gain | 0.3400 |
| X:128052184:TC:T | acceptor_gain | 0.3400 |
| X:128052236:C:T | acceptor_gain | 0.3400 |
| X:128052257:CGT:C | donor_gain | 0.3400 |
| X:128051741:C:CT | donor_gain | 0.3300 |
| X:128051181:A:T | acceptor_gain | 0.3100 |
| X:128051184:CCA:C | acceptor_gain | 0.3100 |
AlphaMissense
2473 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:128051186:A:G | W341R | 0.977 |
| X:128051186:A:T | W341R | 0.977 |
| X:128051559:T:A | K216N | 0.976 |
| X:128051559:T:G | K216N | 0.976 |
| X:128051733:A:C | S158R | 0.976 |
| X:128051733:A:T | S158R | 0.976 |
| X:128051735:T:G | S158R | 0.976 |
| X:128052141:T:A | K22N | 0.975 |
| X:128052141:T:G | K22N | 0.975 |
| X:128051361:G:C | S282R | 0.970 |
| X:128051361:G:T | S282R | 0.970 |
| X:128051363:T:G | S282R | 0.970 |
| X:128051138:A:G | W357R | 0.963 |
| X:128051138:A:T | W357R | 0.963 |
| X:128051148:G:C | F353L | 0.962 |
| X:128051148:G:T | F353L | 0.962 |
| X:128051150:A:G | F353L | 0.962 |
| X:128051826:A:C | F127L | 0.962 |
| X:128051826:A:T | F127L | 0.962 |
| X:128051828:A:G | F127L | 0.962 |
| X:128051179:C:T | G343D | 0.958 |
| X:128051942:A:G | W89R | 0.953 |
| X:128051942:A:T | W89R | 0.953 |
| X:128051632:A:G | L192P | 0.949 |
| X:128051079:A:C | F376L | 0.946 |
| X:128051079:A:T | F376L | 0.946 |
| X:128051081:A:G | F376L | 0.946 |
| X:128051707:G:T | P167H | 0.945 |
| X:128051266:A:G | L314P | 0.944 |
| X:128051749:C:T | G153D | 0.944 |
dbSNP variants (sampled 300 via entrez): RS1000763724 (X:128050538 A>G), RS1000974791 (X:128050972 A>G), RS1002844271 (X:128052385 T>G), RS1003105812 (X:128054344 G>A), RS1006593521 (X:128053422 G>C), RS1006950887 (X:128053885 C>A), RS1009383485 (X:128051024 C>A,T), RS1009435775 (X:128050583 C>T), RS1010008434 (X:128054342 T>A), RS1011060006 (X:128053097 T>C), RS1013836072 (X:128052877 T>C), RS1013908376 (X:128052443 G>A), RS1016188894 (X:128052135 G>A,C), RS1016568477 (X:128053904 G>A,T), RS1017264649 (X:128053477 C>G,T)
Disease associations
OMIM: gene MIM:300487 | disease phenotypes: MIM:309000
GenCC curated gene-disease
Mondo (1): oculocerebrorenal syndrome (MONDO:0010645)
Orphanet (2): Male infertility with azoospermia or oligozoospermia due to single gene mutation (Orphanet:399805), Oculocerebrorenal syndrome of Lowe (Orphanet:534)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007095_120 | Systolic blood pressure | 2.000000e-08 |
| GCST007095_121 | Systolic blood pressure | 8.000000e-08 |
| GCST007097_157 | Pulse pressure | 7.000000e-08 |
| GCST007097_158 | Pulse pressure | 2.000000e-07 |
| GCST012310_26 | Schizophrenia x sex interaction | 7.000000e-06 |
| GCST012310_27 | Schizophrenia x sex interaction | 9.000000e-06 |
| GCST012311_5 | Schizophrenia x sex interaction | 7.000000e-06 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006335 | systolic blood pressure |
| EFO:0005763 | pulse pressure measurement |
| EFO:0008343 | sex interaction measurement |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D009800 | Oculocerebrorenal Syndrome | C10.228.140.163.100.640; C12.050.351.968.419.815.720; C12.200.777.419.815.720; C12.950.419.815.720; C16.131.077.662; C16.320.322.750; C16.320.565.151.600; C16.320.565.189.640; C16.320.709; C16.320.831.750; C18.452.132.100.640; C18.452.648.151.600; C18.452.648.189.640 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
6 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT07410455 | PHASE2 | NOT_YET_RECRUITING | An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome |
| NCT00359515 | Not specified | COMPLETED | Genetic Analysis of Oculocerebrorenal Syndrome of Lowe |
| NCT01314560 | Not specified | COMPLETED | Study of the Pathophysiological Mechanisms Involved in Bleeding Events |
| NCT01793168 | Not specified | RECRUITING | Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford |
| NCT02780297 | Not specified | RECRUITING | Prospective Research Rare Kidney Stones (ProRKS) |
| NCT06065852 | Not specified | RECRUITING | National Registry of Rare Kidney Diseases |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): oculocerebrorenal syndrome